NYACK 2019 Update in Allergy and Asthma

June 8, 2019

This course is designed to provide the practicing clinician, both generalists and allergy and pulmonary specialists, with updates on the diagnosis and management of asthma; food and drug allergies and atopic dermatitis. The didactic lecture component, geared for both generalists and specialists, will focus on recent advances in the evaluation and treatment of asthma and allergies.

Our goal is to provide a unique, interactive course that elucidates the scientific advances which support current clinical practice guidelines for asthma and allergy management.

 

This activity is not supported by educational grants.

 

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Nyack.  The American College of Allergy, Asthma and Immunology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology designates this live activity for a maximum of  4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Target Audience

Practicing clinicians
Allied health professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Have increased knowledge in recent advances in evaluation and treatment of food allergies, including immunotherapy.
  • Have increased knowledge in recent advances in evaluation and management of patients with AERD.
  • Better identify asthma/ Asthma –COPD overlap patients who would benefit from new biologic treatments for better patient outcomes.
  • Accurately diagnose and develop management plans for patients with Anaphylaxis.
Additional information
Disclosure: 

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

John Oppenheimer, MD
  Astra Zeneca – consulting fee
  GlaxoSmithKline – consulting fee, honorarium
  Sanofi – consulting fee

Anna Nowak- Wegrzyn, MD
  Abbott- honorarium 
  Merck – honorarium
  Nutricia- Consulting fee
  Astellas Pharma- Contracted Research
  DBV Technologies- Contracted Research

Geoffrey Chupp, MD
  Genentech- Honorarium
  Sanofi/ Regeneron - Honorarium
  GSK. Boehringer Ingelheim- Honorarium
  Astra Zeneca- Honorarium, Contracted Research, Consulting fee
  Circassia- Honorarium

Kathleen Buchheit, MD
   Roche-  Honorarium
   ALK - Honorarium
   Regeneron - Honorarium


The following have no relevant financial relationships to disclose:
Lourdes de Asis, MD, MPH

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
06/08/2019
Course expires: 
06/08/2021
Event starts: 
06/08/2019 - 8:00am
Event ends: 
06/08/2019 - 1:15pm
Rating: 
0


 

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Please login or create an account to take this course.